Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2023 and 2024.
-
Tight liquidity NBB
Cash and receivables cover 19 % of short-term debt in 2024; threshold 65 %.
-
Busy address KBO
10 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2024
BIO CAP INVEST from Elsene, company number BE0719433261, closed financial year 2024 with a result of € -13,561 after tax. For that financial year BIO CAP INVEST recorded a gross margin of € -5,972 and equity of € 3.9 million. Compared with financial year 2023, the result moved from € -2,491 to € -13,561. The company made a loss. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 4, 2025.
€ 3.9 million
▲ 16% vs 2023
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -13,561
▼ 444 % more loss than in 2023
Profit after tax over the fiscal year.
€ 1,336
▼ 30% vs 2023
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -31,632.
Debts at end 2024
None
No bank loans on the last day of the fiscal year.
€ 7,153
Supplier invoices still open on the last day of the fiscal year.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2021 | 2022 | 2023 | 2024 | Change 2023 → 2024 | |
|---|---|---|---|---|---|
| Gross margin | € -1,060 | € -3,318 | € -1,233 | € -5,972 | ▼ € 4,739 |
| Profit after taxes | € -2,191 | € -4,880 | € -2,491 | € -13,561 | ▼ € 11,070 |
| Equity | € 2,509,300 | € 3,404,493 | € 3,402,002 | € 3,930,400 | ▲ 16% |
| Total debts | € 0 | € 0 | € 0 | € 7,153 | |
| Cash | € 9,280 | € 4,401 | € 1,910 | € 1,336 | ▼ 30% |
| Retained profit | € -10,700 | € -15,580 | € -18,071 | € -31,632 | ▼ € 13,561 |
| Balance sheet total | € 2,509,300 | € 3,404,493 | € 3,402,002 | € 3,937,553 | ▲ 16% |
Key figures of BIO CAP INVEST, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.
What happened to BIO CAP INVEST?
What happened at BIO CAP INVEST in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Jeroen VANGINDERTAEL stepped down as director. NBB
- Michel ALLE stepped down as director. NBB
- An HERREMANS stepped down as director. NBB
- Denis PETTIAUX stepped down as director. NBB
- New annual accounts for financial year 2024: loss of € 13,561. Source: NBB ↗
- Jeroen VANGINDERTAEL became a director. NBB
- Michel ALLE became a director. NBB
- An HERREMANS became a director. NBB
In short
From € 2,191 loss in 2021 to € 13,561 loss in 2024.
A new publication or filing at BIO CAP INVEST? We notify you, reason included.
Follow BIO CAP INVESTDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of Société Anonyme de Participation et de Gestion, AvH Growth Capital comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
BIO CAP INVESTThe shares are held by Société Anonyme de Participation et de Gestion (70.5%) and AvH Growth Capital (22.6%). It owns 9.3% of EPICS THERAPEUTICS itself.
Directors
According to the 2024 annual accounts
since 2023 · until 2027
since 2023 · until 2027
An HERREMANS
Director
Also active at: AANNEMINGSMAATSCHAPPIJ CFE, V.M.A., AGIDENS INTERNATIONAL, OncoDNA, BAARBEEK IMMO, Indigo Diabetes, TURBO'S HOET GROUP, TURBO'S HOET GROUP FINANCE
since 2023 · until 2027
Denis PETTIAUX
Director
Also active at: Tradix, CLOSE OUT SHOP, Société Anonyme de Participation et de Gestion, SOCIETE D'ENTREPRISES ET DE GESTION IMMOBILIERES, BLANCHE II, LHP TRADE, OBJEKTEN, NAZCA +1 more
since 2023 · until 2027
Shareholders
Participations
9.3%
Establishments
Establishment units
Physical locations of this company
Livornostraat 41
1050 Elsene
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 10 companies are registered at this address.
All companies at this address →Collège Royal des Doyens d'Honneur du Travail
Société Anonyme de Participation et de Gestion same network
€ 5.4 million revenue · 2024
BELGIAN INDUSTRIAL COOPERATION
€ 0 gross margin · 2024
SOCIETE D'ENTREPRISES ET DE GESTION IMMOBILIERES same network
€ -2,000 gross margin · 2025
BLANCHE II same network
€ -24,570 gross margin · 2025
+5 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0719.433.261
- VAT number
- BE 0719.433.261
- Registered office
- Livornostraat 41, 1050 Elsene
- Names & denominations
- BIO CAP INVEST
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 25 January 2019
- Peppol
- Active · Active since 20 Nov 2020